Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab
BackgroundImmune checkpoint inhibitors (ICIs) are a standard of care for advanced melanoma but have the potential to cause immune-related adverse events (irAEs), which can vary widely in character and severity. Immune-related airway disease, such as supraglottitis, is a lesser-known and likely under...
| 發表在: | Frontiers in Oncology |
|---|---|
| Main Authors: | , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2025-08-01
|
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1615835/full |
